Steven L. Bender

Statistics

Publications

Citations

3.2K

H-Index

Active since

1981

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Harvard University

Pfizer (United States)

Aduro BioTech (United States)

Dana-Farber Cancer Institute

Steven L. Bender is an author at Genomics Institute of the Novartis Research Foundation specializing in chemistry, organic chemistry, and medicinal chemistry.

Publications per year

1981–2021

Publications

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

Yong Jia, Cai‐Hong Yun, Eunyoung Park et al. · Nature · 2016 · 879 citations · Full text

Medicine, Oncology, Pharmacology +11

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

Helen Y. Zou, Qiuhua Li, Joseph H. Lee et al. · Cancer Research · 2007 · 750 citations · Full text

Medicine, Medicinal Chemistry, Oncology +16

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 438 citations · Full text

Life Sciences, Immunology, Oncology +17

The total synthesis of the polyether antibiotic X-206

David A. Evans, Steven L. Bender, Joel Morris · Journal of the American Chemical Society · 1988 · 239 citations

Pharmacy, Chemistry, Medicinal Chemistry +6

EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor

Yong Jia, Jose Juarez, Jie Li et al. · Cancer Research · 2016 · 121 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 24